Evidence map›Paper›PMID 21962429›Full record

SynthesisAddictive behaviors2012

Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Jennifer Prah Ruger, Christina M Lazar

Abstract readSystematic Review
In one paragraph

Synthesis in Addictive behaviors, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Economic analysis of a multi-site prevention program: assessment of program costs and characterizing site-level variability.Prevention science : the official journal of the Society for Prevention Research · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jennifer Prah RugerYale School of Public Health and Yale School of Medicine, New Haven, CT 06520, USA. Jennifer.ruger@yale.edu
Christina M Lazar
Yale New Haven Health System · USYale University · US

Funding

Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for PregnR01DA025555 · NIDA · YALE UNIVERSITY · PI PRAH RUGER, JENNIFER · 2009 to 2012
$2.6M
Economic Evaluation of Addiction ServicesK01DA016358 · NIDA · YALE UNIVERSITY · PI RUGER, JENNIFER PRAH · 2003 to 2007
$717k
NIDA NIH HHS K01 DA016358NIDA NIH HHS K01DA016358NIDA NIH HHS R01 DA025555NIDA NIH HHS R01DA025555
6 · The paper itself

Abstract

Drug abuse and transmission of HIV during pregnancy are public health problems that adversely affect pregnant women, their children and surrounding communities. Programs that address this vulnerable population have the ability to be cost-effective due to resulting cost savings for mother, child and society. Economic evaluations of programs that address these issues are an important tool to better understand the costs of services and create sustainable healthcare systems. This study critically examined economic evaluations of drug abuse treatment and HIV prevention programs in pregnant women. A systematic review was conducted using the criteria recommended by the Panel on Cost-Effectiveness in Health and Medicine and the British Medical Journal (BMJ) checklist for economic evaluations. The search identified 6 economic studies assessing drug abuse treatment for pregnant women, and 12 economic studies assessing programs that focus on prevention of mother-to-child transmission (PMTCT) of HIV. Results show that many programs for drug abuse treatment and PMTCT among pregnant women are cost-effective or even cost-saving. This study identified several shortcomings in methodology and lack of standardization of current economic evaluations. Efforts to address methodological challenges will help make future studies more comparable and have more influence on policy makers, clinicians and the public.

Indexed as

ChecklistCost-Benefit AnalysisFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, InfectiousPublic HealthSubstance-Related Disorders

Identifiers

PMID21962429
PMCPMC3216632
OpenAlexW3125806355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.